These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Maternal treatment with indomethacin and severe neonatal pulmonary hypertension (author's transl)]. Dalens B; Dechelotte P; Gaulme J; Raynaud EJ Arch Fr Pediatr; 1981 Apr; 38(4):261-5. PubMed ID: 7294953 [TBL] [Abstract][Full Text] [Related]
4. Possible association between maternal indomethacin therapy and primary pulmonary hypertension of the newborn. Manchester D; Margolis HS; Sheldon RE Am J Obstet Gynecol; 1976 Oct; 126(4):467-9. PubMed ID: 985646 [TBL] [Abstract][Full Text] [Related]
5. [Prostaglandin and threat of premature labour inhibitors. 1. The possibilities and consequences (as given in the literature) (author's transl)]. Maria B J Gynecol Obstet Biol Reprod (Paris); 1980; 9(6):721-5. PubMed ID: 7462576 [TBL] [Abstract][Full Text] [Related]
6. A comparison of plasma prostaglandin levels in term and preterm labour. Johnstone MJ Br J Obstet Gynaecol; 1981 Oct; 88(10):1069-71. PubMed ID: 7284287 [No Abstract] [Full Text] [Related]
7. [Hysterographic studies of uterine contractile activity during partusysten treatment of threatened late abortion and premature labor]. Vinnyts'kyĭ OI Pediatr Akus Ginekol; 1979; (4):40-1. PubMed ID: 514659 [No Abstract] [Full Text] [Related]
8. [Is surgical-tocolytic prevention and therapy of cervical insufficiency justified without prenatal diagnostic care?]. Bergner R; Fröhlich HH Zentralbl Gynakol; 1977; 99(26):1624-8. PubMed ID: 607700 [TBL] [Abstract][Full Text] [Related]
9. Persistent pulmonary hypertension in a premature newborn after 16 hours of antenatal indomethacin exposure. Tarcan A; Gürakan B; Yildirim S; Ozkiraz S; Bilezikçi B J Perinat Med; 2004; 32(1):98-9. PubMed ID: 15008397 [TBL] [Abstract][Full Text] [Related]
10. [Magnesium sulfate treatment of threatened late abortions and premature labor]. Penev I; Pavlova F; Naumov I; Shtereva K; Vlasova D Akush Ginekol (Sofiia); 1981; 20(4):265-8. PubMed ID: 7304843 [No Abstract] [Full Text] [Related]
11. [Clinical use of a beta-mimetic drug in the control of uterine dynamics]. Casati G; Scaglione V; Vandelli I Ann Ostet Ginecol Med Perinat; 1973; 94(9-10):587-94. PubMed ID: 4806144 [No Abstract] [Full Text] [Related]
15. [Fetal hydrops following indomethacin administration during pregnancy]. Verboom AJ; de Leeuw R Ned Tijdschr Geneeskd; 1983 Jan; 127(1):18-20. PubMed ID: 6828168 [No Abstract] [Full Text] [Related]
16. Oligohydramnios and transient neonatal anuria: a possible association with the maternal use of prostaglandin synthetase inhibitors. Cantor B; Tyler T; Nelson RM; Stein GH J Reprod Med; 1980 May; 24(5):220-3. PubMed ID: 6772782 [TBL] [Abstract][Full Text] [Related]
17. Renal dysgenesis in a monozygotic twin: association with in utero exposure to indomethacin. Restaino I; Kaplan BS; Kaplan P; Rosenberg HK; Witzleben C; Roberts N Am J Med Genet; 1991 Jun; 39(3):252-7. PubMed ID: 1867274 [TBL] [Abstract][Full Text] [Related]
18. Prostaglandin synthesis inhibition in persistent pulmonary hypertension of the newborn. Turner GR; Levin DL Clin Perinatol; 1984 Oct; 11(3):581-9. PubMed ID: 6488671 [TBL] [Abstract][Full Text] [Related]